A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients-Reference-Cited by-同舟云学术

A phase 1b randomized, placebo‐controlled clinical trial with SNF472 in haemodialysis patients

Published:2019-02-19 Issue:4 Volume:85 Page:796-806
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Salcedo Carolina¹,Joubert Pieter H.¹²,Ferrer Miguel D.¹³,Canals Ana Z.¹,Maduell Francisco⁴,Torregrosa Vicens⁴,Campistol Josep Maria⁴,Ojeda Raquel⁴,Perelló Joan¹⁵^ORCID

Affiliation:

1. Laboratoris Sanifit Palma Spain

2. Institute of Pharmaceutical ScienceKing's College London UK

3. Departament de Biologia Fonamental i Ciències de la SalutUniversitat de les Illes Balears Palma Spain

4. Nephrology DepartmentHospital Clinic Barcelona Spain

5. Laboratori d'Investigació en Litiasi RenalUniversitat de les Illes Balears Palma Spain

Funder

Ministerio de Economía y Competitividad

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13863

Reference36 articles.

1. Arterial Calcifications, Arterial Stiffness, and Cardiovascular Risk in End-Stage Renal Disease

2. Vascular calcification: When should we interfere in chronic kidney disease patients and how?

3. Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis

4. Total and Individual Coronary Artery Calcium Scores as Independent Predictors of Mortality in Hemodialysis Patients

5. Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hexasodium fytate for the treatment of calciphylaxis: a randomised, double-blind, phase 3, placebo-controlled trial with an open-label extension;eClinicalMedicine;2024-09

2. SNF472: a novel therapeutic agent for vascular calcification and calciphylaxis;Journal of Nephrology;2024-03-21

3. Hexasodium fytate exposure-response correlations in a randomized, placebo-controlled study of patients on dialysis with cardiovascular calcification;Frontiers in Pharmacology;2024-02-07

4. Phytates as a natural source for health promotion: A critical evaluation of clinical trials;Frontiers in Chemistry;2023-04-14

5. New Therapeutics Targeting Arterial Media Calcification: Friend or Foe for Bone Mineralization?;Metabolites;2022-04-05